Cargando…
Survivin – biology and potential as a therapeutic target in oncology
Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reve...
Autores principales: | Cheung, Chun Hei Antonio, Huang, Chien-Chang, Tsai, Fang-Ying, Lee, Jane Ying-Chieh, Cheng, Siao Muk, Chang, Yung-Chieh, Huang, Yi-Chun, Chen, Shang-Hung, Chang, Jang-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804542/ https://www.ncbi.nlm.nih.gov/pubmed/24204160 http://dx.doi.org/10.2147/OTT.S33374 |
Ejemplares similares
-
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2020) -
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
por: Lin, Kun-Yuan, et al.
Publicado: (2016) -
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
por: Lin, Tzu-Yu, et al.
Publicado: (2019) -
Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
por: Lee, Jane Ying-Chieh, et al.
Publicado: (2016) -
HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells
por: Huang, Wen-Tsung, et al.
Publicado: (2017)